Triohix Critical Care
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Glipohix 513 Tablet SR is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Glipohix 513 Tablet SR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glipohix 513 Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glipohix 513 Tablet SR.
Glipohix 513 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glipohix 513 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glipohix 513 Tablet SR is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glipohix 513 Tablet SR is a combination of Glimepiride, Metformin, and Voglibose. This medication is used to treat type 2 diabetes mellitus (DM). It works by improving blood glucose levels in adults when taken alongside proper diet and exercise. Glimepiride lowers blood glucose by increasing insulin release from the pancreas. Metformin reduces glucose production in the liver and improves insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, helps lower postprandial (after meal) glucose levels. This combination is not indicated for type 1 DM treatment.
Common side effects associated with Glipohix 513 Tablet SR include hypoglycemia (low blood sugar level), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. Reporting any unusual symptoms to your doctor is essential.
Patients with known allergies to any of the components or excipients of this medicine should avoid using it. Additionally, use is avoided in individuals with moderate to severe kidney disease and those with inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
No, taking Glipohix 513 Tablet SR with alcohol is not advisable. This combination may lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, Glipohix 513 Tablet SR can cause hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. This is more likely to occur if you miss meals, drink alcohol, over-exercise, or take other antidiabetic medications simultaneously. Regular blood sugar monitoring is essential in this case. Keep glucose tablets, honey, or fruit juice with you at all times.
Store Glipohix 513 Tablet SR in its original packaging, tightly closed. Follow the instructions provided on the pack or label. Never dispose of unused medication and ensure pets, children, and other individuals do not access it.